Embria Health Sciences and Praxis Nutri-Pharma have announced that Health Canada has formally approved a new natural health product containing the immune health ingredient EpiCor for the Canadian market. This accreditation, known as Natural Product Number (NPN), gives Canada’s natural health product manufacturers and marketers an opportunity to provide Canada’s consumers a safe and efficacious way to reduce the incidence of cold and flu symptoms.
The approved claim for products containing 500 mg EpiCor is, “helps reduce incidence of cold and flu symptoms.” The significance of this claim is that EpiCor’s research was reviewed using pharmaceutical guidelines and no disclaimers limiting benefits to certain populations are implied.
“This is a significant accomplishment for EpiCor since Health Canada’s process for confirming health claims is perhaps one of the most comprehensive in the world,” said Paul Faganel, Embria Health Sciences President. “The NPN for EpiCor in Canada complements the NDI that EpiCor has on file with the FDA in the United States.”
Press release (pdf)